People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Corcentric, Inc. | — | Other Technology | Series C | $81.2M | $2.5B | 2020 |
| BioMarker Strategies LLC | — | Biotechnology | Seed | $7.9M | $23.3M | 2009 |
Douglas Clark at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Clark on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Glenn Miller | 1 | 5 |
| Brian Hogan | 1 | 4 |
| Tom Brown | 1 | 4 |
| GENE YOON | 1 | 4 |
| Jack Davis | 1 | 3 |
| Matt Clark | 1 | 3 |
| Jason Rubin | 1 | 3 |
| Katarzyna Kusmierz | 1 | 2 |
| Joseph Klein | 1 | 2 |
| Mark Velleca | 1 | 2 |
| Douglas W. Clark | 1 | 1 |
| Michael W. Enright | 1 | 1 |
| Brian W. Hogan | 1 | 1 |
| Mark P. Joyce | 1 | 1 |
| Thomas W. Brown | 1 | 1 |
| Kirk W. Tilley | 1 | 1 |
| Jack W. Gavin | 1 | 1 |
| Paul Beresford | 1 | 1 |
| Christina Wyskiel | 1 | 1 |
| Sam Broder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.